Education and knowledge transfer must be prioritized for industry to see sizable improvement in medical affairs.
Lisa Sigl
Advertisement
Director, Executive Insight, Healthcare Consultants
Articles by Lisa Sigl
How can companies adapt their single evidence package at launch into multiple, tailored versions for HTAs that vary across different countries and regions?
Advertisement
Latest Updated Articles
No Half Measures: How Medical Affairs Can Maximize and Measure ValuePublished: March 25th 2022 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
Novo Nordisk Sends Amended Acquisition Proposal to Metsera
2
Pharmaceutical Executive Daily: Kimberly-Clark’s $48.7 Billion Acquisition of Kenvue
3
FDA Approves Kygevvi Becoming the First Treatment for Thymidine Kinase 2 Deficiency
4
Texas Files to Prevent Kenvue Dividend Payment
5
